文献速递神经肿瘤

使用68Ga-DOTATATE PET用于脑膜瘤患者术后放射外科和放疗计划:病例系列

Using 68 Ga-DOTATATE PET for Postoperative Radiosurgery and Radiotherapy Planning in Patients With Meningioma: A Case Series.
PubMed 文献 · Neurosurgery · 2023-02-01

该病例系列纳入2019年4月至2021年4月间12例病理证实的脑膜瘤患者,先以MRI制定治疗计划,再用68Ga-DOTATATE PET评估肿瘤识别。68Ga-DOTATATE PET改变了12例中5例的既定治疗计划,12例中9例存在MRI未识别的病灶。作者认为该影像对多数患者有临床效用,尤其有助于显示骨内脑膜瘤、鉴别复发与术后改变及识别亚厘米病灶。

要点

  • 12例病理证实的脑膜瘤患者中,68Ga-DOTATATE PET改变了5例的既定治疗计划。
  • 12例中9例存在MRI未识别的病灶。
  • 作者认为该影像尤其有助于显示骨内脑膜瘤、鉴别复发与术后改变及识别亚厘米病灶。

核心结论

  • 在本系列中,纳入68Ga-DOTATATE PET影像对多数使用该检查的患者具有临床效用。
  • 该影像尤其擅长显示骨内脑膜瘤、鉴别复发与术后改变以及识别亚厘米病灶。
  • 作者所在中心将继续把该影像方式用于改善脑膜瘤手术切除后的术后治疗计划。

研究设计与样本

  • 连续病例系列,纳入12例病理证实的脑膜瘤患者,于2019年4月至2021年4月间接受68Ga-DOTATATE PET。
  • 治疗计划先使用MRI制定,随后使用DOTATATE-PET图像评估准确的肿瘤识别。

主要发现

  • 10例为WHO 2级脑膜瘤,2例为1级肿瘤。
  • 8例为复发性脑膜瘤,4例为新诊断疾病。
  • 68Ga-DOTATATE PET扫描改变了12例中5例先前制定的治疗计划。
  • 12例中9例存在MRI未识别的疾病病灶。

临床怎么用

  • 作者所在中心将继续使用68Ga-DOTATATE PET作为改善脑膜瘤手术切除后术后治疗计划的手段。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For patients with either an incompletely resected meningioma or recurrence after surgery, stereotactic radiosurgery is frequently used. MRI is typically used for stereotactic radiosurgery targeting, but differentiating tumor growth from postoperative change can be challenging. 68 Ga-DOTATATE, a positron emission tomography (PET) radiotracer targeting the somatostatin receptor type 2, has been shown to be a reliable meningioma biomarker. OBJECTIVE: To evaluate the impact of 68 Ga-DOTATATE on treatment planning in patients who had previously undergone meningioma resection. METHODS: We present a consecutive case series of 12 patients with pathology-proven meningioma who received a 68 Ga-DOTATATE PET between April 2019 and April 2021. Treatment planning was performed first using MRI. DOTATATE-PET images were then used to assess accurate tumor identification. RESULTS: Ten patients had WHO Grade 2 meningioma, and 2 patients had Grade 1 tumor. Eight patients had recurrent meningiomas, and 4 patients had newly diagnosed disease. Overall, 68 Ga-DOTATATE PET scans altered previously formulated treatment plans in 5 of 12 patients. In addition, 9 of 12 patients had disease foci not appreciated on MRI. CONCLUSION: In this series, incorporating 68 Ga-DOTATATE PET imaging had clinical utility for most patients in whom it was used. It proved particularly adept in demonstrating intraosseous meningiomas, differentiating recurrence from postoperative changes, and identifying subcentimeter disease foci. It is an imaging modality that our center will continue to use as a means of improving postoperative treatment plans after the surgical resection of meningiomas.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Hintz EB, Park DJ, Ma D, et al. Using 68 Ga-DOTATATE PET for Postoperative Radiosurgery and Radiotherapy Planning in Patients With Meningioma: A Case Series. Neurosurgery. 2023. PMID: 36722951. doi:10.1227/neu.0000000000002377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。